A CDC survey suggests America’s obesity rate may be falling.
Key Takeaways
- Recent data shows a slight decline in US obesity rates, but experts caution it’s too early to declare a turning point in the obesity epidemic.
- GLP-1 agonists show promise in combating obesity as trials demonstrate the drugs help people lose 10–20% of their body weight and reduce their risk of weight-related health problems.
- However, the high cost and limited insurance coverage of GLP-1 agonists present significant barriers to widespread adoption, and other preventative initiatives would need to be adopted to keep obesity trends declining.
Ozempic/GLP-1and fast food being way more expensive than it used to be, even if you give them your location and contacts by installing their app, are probably major factors.